Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb;34(2):327-337.
doi: 10.1007/s00198-022-06597-3. Epub 2022 Nov 24.

A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients

Elisabeth Ng  1   2 , Claudia Ashkar  3 , Ego Seeman  4   5 , Hans G Schneider  3   6   7 , Hanh Nguyen  8   9 , Peter R Ebeling  8   9 , Shoshana Sztal-Mazer  3   7
Affiliations

A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients

Elisabeth Ng et al. Osteoporos Int. 2023 Feb.

Abstract

Low serum alkaline phosphatase (ALP) was found in 9% of patients attending an osteoporosis clinic, 0.6% of hospital patients, and 2/22 with an atypical femoral fracture. Hypophosphatasia was diagnosed in 3% of osteoporosis clinic patients with low ALP. Low ALP is a screening tool for hypophosphatasia, a condition potentially aggravated by antiresorptive therapy.

Introduction: Hypophosphatasia (HPP) is an inherited disorder associated with impaired primary mineralisation of osteoid (osteomalacia). HPP may be misdiagnosed as osteoporosis, a reduction in the volume of normally mineralized bone. Both illnesses may result in fragility fractures, although stress and atypical fractures are more common in HPP. Antiresorptive therapy, first-line treatment for osteoporosis, is relatively contraindicated in HPP. Misdiagnosis and mistreatment can be avoided by recognising a low serum alkaline phosphatase (ALP). Our aim was to determine the prevalence of a low ALP (< 30 IU/L) in patients attending an osteoporosis clinic, in a hospital-wide setting, and in a group of patients with atypical femoral fractures (AFF).

Methods: This was a retrospective study of patients attending an osteoporosis clinic at a tertiary hospital during 8 years (2012-2020). Patients were categorised into those with a transiently low ALP, those with low ALP on ≥ 2 occasions but not the majority of measurements, and those with a persistently low ALP. ALP levels were also assessed in hospital-wide records and a group of patients with AFF.

Results: Of 1839 patients attending an osteoporosis clinic, 168 (9%) had ≥ 1 low ALP, 50 (2.7%) had low ALP for ≥ 2 months, and seven (0.4%) had persistently low ALP levels. HPP was diagnosed in five patients, four of whom had persistently low ALP levels. The prevalence of HPP was 0.3% in the osteoporosis clinic and 3% in patients with ≥ 1 low ALP. Low ALP occurred in 0.6% of all hospital patients and 2/22 with AFF.

Conclusion: Persistently low ALP in osteoporosis clinic attendees is easy to identify and signals the possibility of hypophosphatasia, a condition that may be mistaken for osteoporosis and incorrectly treated with antiresorptive therapy.

Keywords: Alkaline phosphatase; Bisphosphonate; Hypophosphatasemia; Hypophosphatasia; Osteoporosis.

PubMed Disclaimer

References

    1. Harvey N, Dennison E, Cooper C (2010) Osteoporosis: impact on health and economics. Nat Rev Rheumatol 6(2):99–105. https://doi.org/10.1038/nrrheum.2009.260 - DOI
    1. Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F (2022) Secondary osteoporosis. Endocr Rev 43(2):240–313 - DOI
    1. Stein E, Shane E (2003) Secondary osteoporosis. Endocrinol Metab Clin North Am 32(1):115–134. https://doi.org/10.1016/S0889-8529(02)00062-2 - DOI
    1. Mornet E (2007) Hypophosphatasia. Orphanet J Rare Dis 2:40. https://doi.org/10.1186/1750-1172-2-40 - DOI
    1. Whyte MP (2008) Chapter 73 - Hypophosphatasia: nature’s window on alkaline phosphatase function in humans. In: Bilezikian JP, Raisz LG, Martin TJ (eds) Principles of bone biology, 3rd edn. Academic Press, San Diego, pp 1573–1598 - DOI

Substances

LinkOut - more resources